MiRXES is a Singaporean biotech company that’s listed on the Hong Kong stock exchange. Today Elaine Boey will be sitting down with co-founder and CEO, Dr. Zhou Lihan to talk about the technology that the company employs, challenges as Southeast Asia’s biotech unicorn, when it might turn profitable, and whether you should be a shareholder.


Image Credit: Shutterstock.com

MiRXES is a Singaporean biotech company that’s listed on the Hong Kong stock exchange. Today Elaine Boey will be sitting down with co-founder and CEO, Dr. Zhou Lihan to talk about the technology that the company employs, challenges as Southeast Asia’s biotech unicorn, when it might turn profitable, and whether you should be a shareholder. Image Credit: <a target="_blank" rel="noopener noreferrer nofollow" href="http://Shutterstock.com">Shutterstock.com</a>

Sharper and stronger than a double espresso. The Morning Run stretches your mind and braces you for the business day. It's your fast track into work where you can hit the ground running. From 6am to 10am weekdays, the Morning Run brings you the biggest stories and must-listen-to interviews. Stay enlightened, make educated business and investment decisions.

The Breakfast Grille

Featuring the cream-of-the-crop as well as the controversial, the Breakfast Grille is the flagship show of BFM. Expect no-holds-barred interviews to get to the truth and into the minds of business leaders, policymakers and changemakers.

MiRXES: Southeast Asia's Biotech Unicorn

Malaysia's durian industry has gone from struggling to meet demand to dealing with a glut but at the very heart of it, it is very much a part of Malaysia. Datuk Anna Teo, founder and Group CEO of Hernan Corporation, a durian grower, processor and exporter, discusses falling prices, rising costs, and whether Malaysia can build a truly world-class durian industry.

Malaysia's durian industry has gone from struggling to meet demand to dealing with a glut but at the very heart of it, it is very much a part of Malaysia. Datuk Anna Teo, founder and Group CEO of Hernan Corporation, a durian grower, processor and exporter, discusses falling prices, rising costs, and whether Malaysia can build a truly world-class durian industry.

Hernan : Uniting Malaysians (and the World) With Durian

Pos Malaysia hasn't turned a profit since 2018 — 32 straight quarters in the red and close to a billion ringgit in accumulated losses. But the first half of 2026 hinted at a shift: losses narrowed to RM63 million, revenue grew 8%, and cash flow turned positive for the first time in years. Group CEO Charles Brewer joins us to explain the pivot from mail to parcels, the push into pawnbroking and digital gold, and whether the national postal operator is genuinely turning the corner — or just had a good six months.

Pos Malaysia hasn't turned a profit since 2018 — 32 straight quarters in the red and close to a billion ringgit in accumulated losses. But the first half of 2026 hinted at a shift: losses narrowed to RM63 million, revenue grew 8%, and cash flow turned positive for the first time in years. Group CEO Charles Brewer joins us to explain the pivot from mail to parcels, the push into pawnbroking and digital gold, and whether the national postal operator is genuinely turning the corner — or just had a good six months.

Pos Malaysia: A Turnaround, Or A Good Six Months?

Malaysia's development financial institutions are carrying RM193.9 billion in financing across 1.8 million accounts — and until now, nobody has formally measured whether that money actually did anything. Bank Negara's new framework changes that, testing DFIs on whether their financing would have happened anyway without them. We put the hard numbers to the man who chairs them: impaired loans running double digits at some members, the payroll-deduction personal loan books, and the RM203.8 million fraud at Agrobank that still hasn't been explained to the public. We speak to YBhg Dato' Muzaffar Hisham, Chairman of ADFIM and Group CEO of Bank Pembangunan Malaysia.

Malaysia's development financial institutions are carrying RM193.9 billion in financing across 1.8 million accounts — and until now, nobody has formally measured whether that money actually did anything. Bank Negara's new framework changes that, testing DFIs on whether their financing would have happened anyway without them. We put the hard numbers to the man who chairs them: impaired loans running double digits at some members, the payroll-deduction personal loan books, and the RM203.8 million fraud at Agrobank that still hasn't been explained to the public. We speak to YBhg Dato' Muzaffar Hisham, Chairman of ADFIM and Group CEO of Bank Pembangunan Malaysia.

MiRXES: Southeast Asia's Biotech Unicorn

In 1 playlist(s)

The Breakfast Grille

Social links

Follow podcast

Recent clips